Three Influenza Vaccines Are Optimal For Adults 65 And Older, CDC Panel Votes

 
• By Brenda Sandburg

Higher dose or adjuvanted seasonal flu vaccines – Fluzone, Fluad and Flubok – provide benefit over other vaccines for older adults, advisory committee concludes. Merck’s PCV15 pneumococcal vaccine and GSK’s Priorix MMR vaccine are recommended for pediatric use by ACIP.

Influenza vaccine
CDC advisory panel recommends high dose or adjuvanted influenza vaccines in those 65 and older • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers